Abstract

Veeva Systems Inc. is scheduled to release fiscal second-quarter 2027 results on August 26, 2026 Post-Mkt, with investors watching revenue growth, margin stability, and subscription momentum against company guidance and consensus.

Market Forecast

Consensus for the current quarter points to revenue of about 905.30 million US dollars, up 17.81% year over year, and adjusted EPS near 2.22, up 16.99% year over year; the EBIT estimate is 394.86 million US dollars, up 16.86% year over year. The company’s prior update indicated current-quarter revenue guidance of 902.00–905.00 million US dollars and adjusted EPS of 2.21–2.22; there is no explicit gross margin or net margin guidance, and the market will benchmark any commentary against last quarter’s 74.98% gross profit margin and 29.55% net profit margin. The main business remains anchored by recurring subscription revenue and steady services delivery, with recent large-customer commitments suggesting resilient demand across commercial and R&D product families. Subscription Services—with last quarter revenue of 730.18 million US dollars and most recently disclosed segment growth of 16% year over year in the preceding quarter—continues to be the most promising contributor to top-line expansion.

Last Quarter Review

Veeva Systems Inc. delivered last quarter revenue of 882.95 million US dollars, up 16.32% year over year, a gross profit margin of 74.98%, GAAP net profit attributable to the parent company of 261.00 million US dollars, a net profit margin of 29.55%, and adjusted EPS of 2.24, up 13.71% year over year. A notable highlight was consistent operating leverage, with EBIT of 395.38 million US dollars rising 13.00% year over year while revenue growth remained in the mid‑teens, underscoring disciplined cost execution alongside growth investments. In the business mix, Subscription Services contributed 730.18 million US dollars last quarter, and in the most recently disclosed quarter with segment growth detail Subscription Services increased 16% year over year, reinforcing the recurring-revenue engine.

Current Quarter Outlook

Subscription Services momentum and mix

Subscription Services is positioned to carry the growth load again this quarter, supported by a robust backlog and a cadence of new logo wins and expansions among large enterprises. The company’s guidance—902.00–905.00 million US dollars of total revenue and adjusted EPS of 2.21–2.22—implicitly assumes continued mid‑teens top-line expansion, in line with the 17.81% consensus year‑over‑year growth estimate. Against last quarter’s 74.98% gross margin and 29.55% net margin, stability in the subscription and services mix should be closely watched because incremental strength in subscriptions typically supports margin resilience while a heavier services mix can cap upside. Execution risk is tied less to demand signals and more to timing of go‑lives and phased deployments that drive revenue recognition; a clean conversion of late‑quarter activations would support reported revenue landing toward the high end of the company’s range.

Demand indicators are favorable. The commitment cadence by large enterprises to the company’s commercial applications, along with expansions in development and quality use cases, has created a diversified base of recurring contracts. Expansion selling into existing accounts is a recurring theme, supported by cross‑suite adoption patterns. Normal quarter-to-quarter variability can arise from implementation milestones and usage factors, but a subscription-heavy mix and previously communicated revenue range suggest a path to consensus revenue and adjusted EPS.

Margin dynamics should reflect scale benefits and the relative contribution of subscription versus services. With last quarter’s Subscription Services revenue at 730.18 million US dollars and services at 152.77 million US dollars, an incremental tilt toward subscription revenue this quarter would help defend the gross margin baseline set last quarter. Conversely, a temporarily higher services contribution could slightly dampen consolidated gross margins even if it accelerates time-to-value for customers and supports future subscription upsells; investors will parse commentary for color on services capacity and attach rate.

Vault CRM and agentic/AI initiatives

Momentum around the newer commercial customer‑engagement platform continues to matter for both near‑term bookings and long‑term growth visibility. Recent milestones include a global commitment by Eli Lilly to adopt Vault CRM, as well as previously disclosed enterprise selections by other large companies; these signals point to expanding adoption in complex global environments. The company has also discussed progress in releasing AI agents across major application areas and in launching an agentic platform to support development programs, which together can lift attach rates and enhance the value proposition of existing suites.

What matters this quarter is not only the headline count of commitments, but also progress markers such as the number of customers live, deployment scope expanding within large accounts, and the emergence of cross‑module usage that reinforces subscription durability. The presence of more than one hundred customers live on the modern CRM platform in prior updates and the continued addition of large reference clients raise the likelihood that expansions will contribute incrementally to fiscal 2H performance. While revenue from these initiatives flows mostly through Subscription Services, the initial phases can temporarily increase services activity; over time, at‑scale operations should support subscription growth while maintaining margins, particularly if agentic features can streamline workflows and increase end‑user adoption.

AI‑enabled features within commercial and content workflows may become a differentiator in customer renewals and expansions. Investors should look for quantified examples of customer productivity improvements, early monetization pathways for AI modules, and evidence that AI features are becoming embedded in standard deployments. Any commentary that connects AI adoption to uplift in per‑seat or per‑module economics would be a constructive signal for medium‑term revenue and margin quality.

What could move the stock around the print

Three factors stand out for potential share‑price impact around the release. First, the alignment of reported revenue and adjusted EPS with the 905.30 million US dollars and 2.22 consensus will set the tone; a print that clears the top end of the company’s 902.00–905.00 million US dollars revenue range and holds adjusted EPS at or slightly above 2.22 would likely validate the trajectory implied by current estimates. Second, qualitative guidance on margin direction—relative to last quarter’s 74.98% gross margin and 29.55% net margin—could sway expectations for the remainder of fiscal 2027, especially if management frames a path for maintaining margins while funding go‑to‑market and R&D initiatives tied to newer platforms.

Third, update cadence on large‑customer migrations and new global adoptions will be closely monitored because these expansions underpin durable subscription growth. Named wins like the global deployment at Eli Lilly, along with earlier announcements of selections by major enterprises, support the case for sustained momentum; investors will look for commentary on implementation milestones and ramp schedules that can translate into revenue timing. In the background, inclusion in major equity indices earlier in the year has influenced flows and could dampen volatility provided the company meets or modestly exceeds its own guide; however, any indication of pushouts in projects or a services mix shift greater than expected could modulate near‑term multiples even if the multi‑quarter pipeline remains healthy.

Analyst Opinions

The collected views are overwhelmingly bullish, with a bullish‑to‑bearish ratio effectively 10:0 across recent notes and rating actions. Several well‑known institutions have reiterated positive stances with explicit price targets and supportive fundamental narratives. BTIG’s David Larsen maintained a Buy rating and a 340.00 US dollars price target following a stronger‑than‑expected fiscal first quarter and a raised outlook, citing continued momentum in newer platforms and AI initiatives that can deepen product usage over time. Wells Fargo’s Stan Berenshteyn maintained a Buy and set a 320.00 US dollars target, reflecting confidence that subscription revenue growth will remain in the mid‑teens and that execution risk is manageable within the current guidance framework. Barclays’ Saket Kalia reaffirmed a Buy rating with a 250.00 US dollars target, emphasizing sustained demand patterns and a mix that supports durable high‑margin recurring revenue.

RBC Capital’s Rishi Jaluria reiterated a Buy and a 275.00 US dollars target, pointing to successful large‑customer commitments and the runway for modern commercial deployments; Piper Sandler’s Hannah Rudoff maintained a Buy with a 285.00 US dollars target, highlighting that adoption indicators and the existing customer base can support ongoing cross‑suite expansion. Stifel most recently maintained a Buy while lifting its target to 275.00 US dollars, noting that the visibility into bookings and the cadence of platform rollouts provide an underpinning for second‑half estimates. JPMorgan kept an Overweight rating with a 272.00 US dollars target as it recalibrated assumptions but kept the core thesis intact; Jefferies maintained a Buy while adjusting its target to 250.00 US dollars, and Baird reiterated Outperform with a 260.00 US dollars target, both underscoring that current growth and profitability remain well‑aligned with the subscription model’s economics.

On the substance of the bull case heading into the print, analysts broadly converge on three points. First, they see the company’s revenue guide of 902.00–905.00 million US dollars as appropriately conservative relative to the 905.30 million US dollars consensus and believe that adoption momentum in commercial customer‑engagement products, along with expansions in development and quality use cases, supports the mid‑teens growth implied. Second, they anticipate margin steadiness given the subscription‑heavy mix and last quarter’s 74.98% gross margin and 29.55% net margin; to the extent services delivery scales to support complex deployments, analysts still expect adjusted EPS near 2.22, up 16.99% year over year. Third, they consider continued enterprise‑level commitments—exemplified by Eli Lilly’s global decision—as strong validation of product readiness for large, regulated global environments, with the potential for follow‑on modules and agentic features to raise long‑term account value.

The bullish view also links near‑term execution to longer‑run value creation. Analysts argue that consistent conversion of committed deployments to live production environments and the embedding of AI features in day‑to‑day workflows can enlarge addressable usage within existing accounts. If the company can maintain mid‑teens revenue expansion, protect gross margin near recent levels, and translate AI and platform investments into attachable modules, the medium‑term path for adjusted EPS growth above revenue growth remains plausible in their models. Heading into August 26, 2026, these institutions appear to be looking for a result that meets or modestly beats the top end of the guide and a qualitative update that keeps the fiscal 2027 trajectory intact, especially around the cadence of customer go‑lives and the early monetization of new capabilities.

In sum, the prevailing institutional stance is clearly supportive ahead of the release: the majority of high‑profile analysts reaffirm Buy or Overweight ratings with targets spanning 250.00 to 340.00 US dollars, anchored in confidence that subscription momentum, expanding large‑customer commitments, and a disciplined margin profile can sustain mid‑teens top‑line growth and healthy per‑share earnings progression this quarter and beyond.